News tagged with stem cell transplants

Oral inhibitor shows clinical activity in poor-prognosis AML

An oral targeted drug has shown encouraging activity and tolerable side effects in patients with treatment-resistant or relapsed acute myelogenous leukemia (AML) - a poor-prognosis group with few options - report investigators ...

Dec 08, 2014
popularity not rated yet | comments 0